Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    "Schizophrenia, Paranoid"
Show Display Options
Rank Status Study
1 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)
2 Completed MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
Conditions: Paranoid Schizophrenia;   Schizophrenia
Interventions: Drug: MK0557;   Drug: Comparator: Placebo (unspecified)
3 Completed
Has Results
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Intervention: Drug: asenapine
4 Completed
Has Results
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)
Conditions: Schizophrenia, Paranoid;   Schizophrenia, Disorganized;   Schizophrenia, Undifferentiated
Interventions: Drug: asenapine 2.5 mg;   Drug: asenapine 5.0 mg;   Drug: placebo
5 Unknown  Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Conditions: Schizophrenia, Catatonic;   Schizophrenia, Disorganized;   Schizophrenia, Paranoid;   Schizophrenia;   Psychotic Disorders
Intervention: Drug: Long-acting Risperidone microspheres injection
6 Unknown  Cognitive Determinants of Psychoeducation and Information in Psychoses
Conditions: Schizophrenia;   Delusional Disorders (ICD-10)
Intervention: Behavioral: COGPACK training, psychoeducation
7 Completed Acceptance and Commitment Therapy for Delusions
Conditions: Schizophrenia;   Delusional Disorder
Intervention: Behavioral: Acceptance and Commitment Therapy
8 Completed A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
Conditions: Schizophrenia;   Mania;   Delusional Disorder;   Acute Exacerbation of Psychosis
Intervention: Drug: Ziprasidone
9 Unknown  Trial of Cognitive Behavioral Therapy for Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention: Behavioral: Cognitive Behavioral Therapy
10 Active, not recruiting Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
Conditions: Schizophrenia;   Delusional Disorder;   Schizoaffective Disorder;   Brief Psychotic Disorder;   Schizophreniform Disorder
Interventions: Behavioral: CBT-E;   Behavioral: Treatment as Usual
11 Recruiting D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Interventions: Drug: D-Cycloserine;   Drug: Placebo;   Behavioral: Cognitive Behavioral Therapy
12 Terminated Anticholinergic Burden in Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorders
Intervention: Drug: Benztropine
13 Terminated Schizophrenic Patients Taking Part in Integrated Care Program
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreni-form Disorder;   Delusional Disorder;   Psychotic Disorder Not Otherwise Specified
Intervention:
14 Unknown  Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
Conditions: Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder
Intervention:
15 Completed Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychosis
Intervention: Behavioral: Multi-element, team-oriented treatment
16 Completed Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorder
Intervention: Drug: Risperidone/Olanzapine and PET scans
17 Unknown  Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
Conditions: Psychotic Disorders;   Schizophrenia;   Schizoaffective Disorder;   Delusional Disorder;   Schizophreniform Disorder
Intervention: Behavioral: modified cognitive behavioural therapy (mCBT)
18 Completed
Has Results
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Behavioral: Cognitive Behavioral Therapy
19 Recruiting Integrated Care in Psychotic Disorders With Severe Mental Illness
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Delusional Disorder;   Psychotic Disorder NOS;   Bipolar Disorder;   Severe Major Depression With Psychotic Features
Intervention: Other: Integrated care
20 Active, not recruiting Improving Work Outcome for People With Severe Mental Illness
Conditions: Schizophrenia, Schizotypal and Delusional Disorders;   Bipolar Affective Disorder;   Recurrent Depressive Disorder
Interventions: Behavioral: Individual Placement and support (IPS);   Behavioral: IPS plus

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.